Coronavirus Diagnostics Market Next Big Thing | Major Giants Beckman Coulter, Hologic, Perkin Elmer

Latest Research Study on Global Coronavirus Diagnostics Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Coronavirus Diagnostics Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Coronavirus Diagnostics. F. Hoffmann-La Roche AG (Switzerland), Bio-Rad Laboratories Inc. (United States), Beckman Coulter Inc. (United States), Becton, Dickinson, and Company (United States), Lonza Group AG (Switzerland), Hologic, Inc. (United States), QIAGEN (Germany), GlaxoSmithKline Biologicals SA (Belgium), Abbott Laboratories (United States), Perkin Elmer, Inc. (United States), Neuberg Diagnostics (India), 1drop Inc. (Switzerland), Veredus Laboratories (Hong Kong), ADT Biotech (Malaysia), Quest Diagnostics (United States), LabCorp (United States), altona Diagnostics GmbH (Germany), bioMérieux SA (France) and Mylab Discovery Solutions Pvt Ltd. (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aldatu Biosciences (United States), Quidel Corporation (United States), Luminex Corporation (United States) and Cepheid Inc. (United States).

Free Sample Report + All Related Graphs & Charts @ : https://www.advancemarketanalytics.com/sample-report/129953-global-coronavirus-diagnostics-market

Covid-19 is an infectious disease caused by a newly discovered coronavirus. The name Covid-19 represents the virus's membership of the coronavirus family, with its first human interaction noted in 2019. Coronavirus is the term coined for the family of viruses that are transmitted between animals and humans. Hence they are also known as zoonotic viruses. In addition, the virus outbreak was confirmed on March 27, 2020, on six continents and in more than 197 countries. According to the World Health Organization (WHO), fever, fatigue and dry cough are common symptoms of Covid-19 infection. Other symptoms of the disease include shortness of breath, sore throat, pain, and diarrhea in some cases, as well as nausea or a runny nose.

In addition, this infection can spread from one person to another through droplets of saliva, or it can leak out of the nose when an infected person coughs or sneezes. The time from a person's exposure to Covid-19 to the onset of symptoms is generally between two and fourteen days, with an average of five days. The current status of lead COVID testing is toward increasing capacity but mixed accuracy. For efficient and accurate COVID-19 diagnosis, doctors need a portable or on-site diagnostic test to be able to manage patients in real-time in the shortest possible time. This has encouraged the introduction of point-of-care (POC) tests for diagnosis, the primary aim of which is to cut test times from hours to minutes.

The most common concern of the governments of all nations affected by Covid-19 is the intolerable need to screen and test large numbers of patients for possible Sars-Cov-2 infections. As a result, most of them face significant bottlenecks in the supply of diagnostic kits to test for the virus. Diagnostic virology companies have been under immense pressure so as to provide reliable test kits and also the demand for the in vitro or point-of-care testing capabilities in the laboratories in various countries is also increasing. However, with the introduction of automated SARS-CoV-2 test systems, the diagnosis increases its capacity to carry out such tests considerably. However, currently, only a few companies are focused on developing rapid immunoassay tests for Covid-19 diagnosis.

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/129953-global-coronavirus-diagnostics-market

Market Trend
• A Shift in Focus from Centralized Laboratories to Decentralized Point-Of-Care Testing
• An Upsurge in Validating and Developing Rapid POC Immunodiagnostic Tests to Facilitate Decentralized Testing
• Growing Trend of Incorporation of Artificial Intelligence (AI) in the COVID-19 Tests for Rapid and Efficient Diagnosis

Market Drivers
• The Increasing Global Prevalence of COVID-19
• Unavailability of Specific Medicine or a Vaccine for the Coronavirus Disease
• An Increase in the Need for Developing Diagnostic Tests Owing to the Global Conditions
• The Increased Demand for Rapid Immunoassay Tests for Disease Diagnosis

Opportunities
• Growth in Funding For Research on Coronavirus Diagnostics
• Increasing Application of Molecular Diagnostic Technologies in Pharmacogenetics and Point-Of-Care Testing
• The Rise in Integration of Novel Technologies and Software Solutions with COVID-19 Testing

Restraints
• Lack of Awareness among Developing Countries Regarding the Necessary Precautions to Be Taken

Challenges
• Shortage of Medical Professionals That Have Sufficient Knowledge Regarding the Use of Diagnostic Kits for COVID-19

Extracts from Table of Contents
Chapter 1: Coronavirus Diagnostics Market Overview
Chapter 2: Global Coronavirus Diagnostics Market Share and Market Overview
Chapter 3: Coronavirus Diagnostics Market Manufacturers/Players Analysis
3.1 Market Concentration Rate
3.2 Competition Scenario: BCG Matrix [Relative Market Share v/s Revenue Growth Rate]
3.3 Heat Map Analysis
3.4 Comparative Market Share Analysis by Players (2018-2019) Rank, [% Market Share, Market Revenue]
3.5 Company Profile - Business Distribution by Region, Interview Record, Business Profile, Product/Service Specification, Price, Revenue and Gross profit 2017-2019
3.6 Price Benchmarking (2017-2019)
Chapter 4: Global Coronavirus Diagnostics Market Segmentation (Country Level Breakdown) (2014-2025)
• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, and Brazil.
• Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.
• Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands, Poland and Russia.
• Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.
Chapter 5: Global Coronavirus Diagnostics Market Breakdown by Segments (by Type (Molecular, Serology, Antigen-Based), Product Used (Instruments, Reagents & Kits), Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-CoV), End-Users (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Diagnostic Centers and Clinics, Research Institutes, Others), Sample Type (Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swab), Mode of Diagnosis (Point-of-Care (POC), Non-Point-of-Care (Non-PoC)))
5.1 Global Coronavirus Diagnostics Market Segmentation (Product Type) Market Size 2014-2025
5.2 Different Coronavirus Diagnostics Price Analysis by Product Type (2014-2025)
5.3 Global Coronavirus Diagnostics Market Segmentation (Product Type) Analysis
5.4 Global Coronavirus Diagnostics Market by Application/End users Market Size 2014-2025
5.5 Global Coronavirus Diagnostics Market Segmentation (other segments) Analysis
Chapter 6: Methodology/Research Approach, Data Source, Disclaimer

Get More Information: https://www.advancemarketanalytics.com/reports/129953-global-coronavirus-diagnostics-market

Data Sources & Methodology

The primary sources involves the industry experts from the Global Coronavirus Diagnostics Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

Buy the Latest Detailed Report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=129953

What benefits does AMA research studies provides?
• Supporting company financial and cash flow planning
• Latest industry influencing trends and development scenario
• Open up New Markets
• To Seize powerful market opportunities
• Key decision in planning and to further expand market share
• Identify Key Business Segments, Market proposition & Gap Analysis
• Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@advancemarketanalytics.com

Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport

About Author:
Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies' revenues.
Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

This release was published on openPR.